These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14635022)

  • 1. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.
    Babiuk S; Skowronski DM; De Serres G; HayGlass K; Brunham RC; Babiuk L
    J Med Virol; 2004 Jan; 72(1):138-42. PubMed ID: 14635022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?
    Skowronski DM; Lu H; Warrington R; Hegele RG; De Serres G; HayGlass K; Stark D; White R; Macnabb J; Li Y; Manson HE; Brunham RC
    J Infect Dis; 2003 Feb; 187(3):495-9. PubMed ID: 12552434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza.
    Williman J; Young S; Buchan G; Slobbe L; Wilson M; Pang P; Austyn J; Preston S; Baird M
    Vaccine; 2008 Sep; 26(40):5153-8. PubMed ID: 18456374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection.
    Mann JF; Shakir E; Carter KC; Mullen AB; Alexander J; Ferro VA
    Vaccine; 2009 Jun; 27(27):3643-9. PubMed ID: 19464545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection.
    Moran TM; Park H; Fernandez-Sesma A; Schulman JL
    J Infect Dis; 1999 Sep; 180(3):579-85. PubMed ID: 10438342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
    Hovden AO; Cox RJ; Haaheim LR
    Scand J Immunol; 2005 Jul; 62(1):36-44. PubMed ID: 16092921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse chorionic gonadotropin beta-subunit-like (muCG beta l) molecule produced by tumor cells elicits the switch of T-cell immunity response from TH2 to TH1 in mice immunized with DNA vaccine based on rhesus monkey homologous CG beta (rmCG beta).
    Shi SQ; Peng JP; Xu L; Yang Y; Chen Y
    J Gene Med; 2005 Jan; 7(1):87-96. PubMed ID: 15517553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
    Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
    Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of influenza vaccine formulation with a detailed analysis of the cytokine response.
    Szyszko E; Brokstad K; Cox RJ; Hovden AO; Madhun A; Haaheim LR
    Scand J Immunol; 2006 Nov; 64(5):467-75. PubMed ID: 17032238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
    Singh V; Agrewala JN
    BMC Immunol; 2006 Aug; 7():17. PubMed ID: 16889674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice.
    Minne A; Jaworska J; Gerhold K; Ahrens B; Avagyan A; Vanbever R; Matricardi PM; Schmidt AC; Hamelmann E
    Clin Exp Allergy; 2007 Aug; 37(8):1250-8. PubMed ID: 17651156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity.
    Chen D; Burger M; Chu Q; Endres R; Zuleger C; Dean H; Payne LG
    Virus Res; 2004 Jul; 103(1-2):147-53. PubMed ID: 15163503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains.
    Wareing MD; Harrison LC; Tannock GA
    Vaccine; 2005 Jul; 23(31):4075-81. PubMed ID: 15963362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
    Hauge S; Madhun AS; Cox RJ; Brokstad KA; Haaheim LR
    Scand J Immunol; 2007 Jan; 65(1):14-21. PubMed ID: 17212762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.